Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ardent Health (ARDT) EBITDA Margin (2023 - 2025)

Historic EBITDA Margin for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to 17.64%.

  • Ardent Health's EBITDA Margin fell 42000.0% to 17.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.2%, marking a year-over-year increase of 30700.0%. This contributed to the annual value of 11.23% for FY2024, which is 43300.0% up from last year.
  • Per Ardent Health's latest filing, its EBITDA Margin stood at 17.64% for Q3 2025, which was down 42000.0% from 9.03% recorded in Q2 2025.
  • Over the past 5 years, Ardent Health's EBITDA Margin peaked at 6.03% during Q4 2024, and registered a low of 17.89% during Q4 2023.
  • Its 3-year average for EBITDA Margin is 13.07%, with a median of 13.47% in 2023.
  • As far as peak fluctuations go, Ardent Health's EBITDA Margin surged by 118700bps in 2024, and later plummeted by -42000bps in 2025.
  • Over the past 3 years, Ardent Health's EBITDA Margin (Quarter) stood at 17.89% in 2023, then skyrocketed by 66bps to 6.03% in 2024, then tumbled by -193bps to 17.64% in 2025.
  • Its EBITDA Margin stands at 17.64% for Q3 2025, versus 9.03% for Q2 2025 and 12.33% for Q1 2025.